Haoxin Wu

749 total citations
34 papers, 559 citations indexed

About

Haoxin Wu is a scholar working on Biological Psychiatry, Neurology and Molecular Biology. According to data from OpenAlex, Haoxin Wu has authored 34 papers receiving a total of 559 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Biological Psychiatry, 10 papers in Neurology and 9 papers in Molecular Biology. Recurrent topics in Haoxin Wu's work include Tryptophan and brain disorders (13 papers), Neuroscience and Neuropharmacology Research (8 papers) and Neuroinflammation and Neurodegeneration Mechanisms (6 papers). Haoxin Wu is often cited by papers focused on Tryptophan and brain disorders (13 papers), Neuroscience and Neuropharmacology Research (8 papers) and Neuroinflammation and Neurodegeneration Mechanisms (6 papers). Haoxin Wu collaborates with scholars based in China, Israel and Hong Kong. Haoxin Wu's co-authors include Hailou Zhang, Wenda Xue, Weiwei Tao, Gang Chen, Li Ren, Baomei Xia, Ruyan Wu, Juanjuan Tang, Yan Sun and Chang Chen and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and British Journal of Pharmacology.

In The Last Decade

Haoxin Wu

31 papers receiving 553 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Haoxin Wu China 13 243 161 138 120 97 34 559
Rong-Hao Mu China 13 174 0.7× 148 0.9× 68 0.5× 114 0.9× 124 1.3× 17 471
Vanessa Gómez‐Rangel Spain 10 163 0.7× 238 1.5× 76 0.6× 59 0.5× 105 1.1× 12 596
Lijuan Tong China 18 363 1.5× 276 1.7× 81 0.6× 111 0.9× 240 2.5× 32 914
Hongkun Bao China 12 127 0.5× 166 1.0× 118 0.9× 33 0.3× 67 0.7× 21 431
Hyun Soo Shim South Korea 17 85 0.3× 238 1.5× 70 0.5× 118 1.0× 73 0.8× 34 755
Satendra Singh Gurjar India 8 167 0.7× 100 0.6× 39 0.3× 52 0.4× 102 1.1× 10 459
Lina Gao China 12 115 0.5× 234 1.5× 94 0.7× 116 1.0× 40 0.4× 21 666
Sam-Hip Tsai Hong Kong 8 157 0.6× 122 0.8× 79 0.6× 100 0.8× 141 1.5× 9 458
Rungtip Soi‐ampornkul Thailand 11 86 0.4× 141 0.9× 83 0.6× 89 0.7× 60 0.6× 20 475

Countries citing papers authored by Haoxin Wu

Since Specialization
Citations

This map shows the geographic impact of Haoxin Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haoxin Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haoxin Wu more than expected).

Fields of papers citing papers by Haoxin Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haoxin Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haoxin Wu. The network helps show where Haoxin Wu may publish in the future.

Co-authorship network of co-authors of Haoxin Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Haoxin Wu. A scholar is included among the top collaborators of Haoxin Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haoxin Wu. Haoxin Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hua, Shao‐Ying, Xinyi Chen, Min Ni, et al.. (2025). ZeXieYin formula alleviates atherosclerosis by regulating SBAs levels through the FXR/FGF15 pathway and restoring intestinal barrier integrity. Chinese Medicine. 20(1). 68–68. 1 indexed citations
3.
5.
Xu, Ping, Wenxia Zhou, Yu Zuo Bai, et al.. (2025). Alisol A ameliorates vascular cognitive impairment via AMPK/NAMPT/SIRT1-mediated regulation of cholesterol and autophagy. Theranostics. 15(18). 9415–9446. 1 indexed citations
6.
Sun, Yan, et al.. (2024). Zexieyin formula alleviates atherosclerosis with cognitive impairment: A novel role in the treatment of comorbidities and its underlying mechanisms. Journal of Ethnopharmacology. 323. 117715–117715. 5 indexed citations
7.
Zhang, Chencheng, Ke Pei, Renjun Gu, et al.. (2024). Mechanism of Yishen Chuchan decoction intervention of Parkinson's disease based on network pharmacology and experimental verification. Heliyon. 10(14). e34823–e34823. 2 indexed citations
10.
Wei, Feili, Haoxin Wu, Shan Guo, et al.. (2024). Clinical evaluation of droplet digital pcr for suspected ascites infection in patients with liver cirrhosis. Hepatology International. 18(4). 1249–1260.
11.
Sun, Yan, et al.. (2023). ZeXieYin Formula alleviates TMAO-induced cognitive impairment by restoring synaptic plasticity damage. Journal of Ethnopharmacology. 314. 116604–116604. 12 indexed citations
12.
Sun, Yan, et al.. (2023). PI3K/AKT/SERBP-1 pathway regulates Alisma orientalis beverage treatment of atherosclerosis in APOE −/− high-fat diet mice. Pharmaceutical Biology. 61(1). 473–487. 10 indexed citations
13.
Sun, Yan, et al.. (2023). Pyrolae herba alleviates cognitive impairment via hippocampal TREM2 signaling modulating neuroinflammation and neurogenesis in lipopolysaccharide-treated mice. Journal of Ethnopharmacology. 319(Pt 2). 117214–117214. 5 indexed citations
14.
Zhang, Hailou, Yan Sun, Suk‐Yu Yau, et al.. (2022). Synergistic effects of two naturally occurring iridoids in eliciting a rapid antidepressant action by up‐regulating hippocampal PACAP signalling. British Journal of Pharmacology. 179(16). 4078–4091. 33 indexed citations
15.
Yin, Ying, Yifan Chen, Yan Sun, et al.. (2021). Latent Sex Differences in CaMKII-nNOS Signaling That Underlie Antidepressant-Like Effects of Yueju-Ganmaidazao Decoction in the Hippocampus. Frontiers in Behavioral Neuroscience. 15. 640258–640258. 5 indexed citations
16.
Wei, Yanan, et al.. (2020). Alisma orientalis Beverage Treats Atherosclerosis by Regulating Gut Microbiota in ApoE-/- Mice. Frontiers in Pharmacology. 11. 570555–570555. 41 indexed citations
17.
Wang, Wei, Tong Zhou, Hailou Zhang, et al.. (2019). NMDA receptors and L-arginine/nitric oxide/cyclic guanosine monophosphate pathway contribute to the antidepressant-like effect of Yueju pill in mice. Bioscience Reports. 39(9). 9 indexed citations
18.
Huang, Zhiheng, Jie Xu, Xiaoyan Huang, et al.. (2019). Crocin induces anti-ischemia in middle cerebral artery occlusion rats and inhibits autophagy by regulating the mammalian target of rapamycin. European Journal of Pharmacology. 857. 172424–172424. 19 indexed citations
19.
Xia, Baomei, Hailou Zhang, Wenda Xue, et al.. (2016). Instant and Lasting Down-Regulation of NR1 Expression in the Hippocampus is Associated Temporally with Antidepressant Activity After Acute Yueju. Cellular and Molecular Neurobiology. 36(7). 1189–1196. 20 indexed citations
20.
Jiang, Lihua, Lingling Wang, Mingyan Wang, et al.. (2012). Pinching spine: A potential treatment for depression. Chinese Journal of Integrative Medicine. 20(4). 272–279. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026